Nomura Holdings Inc Coherus Bio Sciences, Inc. Transaction History

Nomura Holdings Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $75,191 - $182,066	47,290 Added 225.08%	68,300 $227,000
Q3 2023 Nov 14, 2023	SELL	$3.74 - $5.45 $169,822 - $247,468	-45,407 Reduced 68.37%	21,010 $78,000
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $7,136 - $15,628	-1,883 Reduced 2.76%	66,417 $283,000
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $133,267 - $238,025	22,626 Added 49.54%	68,300 $467,000
Q3 2022 Nov 15, 2022	BUY	$7.17 - $13.87 $154,327 - $298,537	21,524 Added 89.13%	45,674 $441,000
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $200,119 - $451,804	-34,150 Reduced 58.58%	24,150 $189,000
Q1 2022 May 18, 2022	BUY	$10.92 - $16.41 $310,805 - $467,061	28,462 Added 95.39%	58,300 $749,000
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $94,243 - $113,199	-5,961 Reduced 16.65%	29,838 $476,000
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $152,007 - $213,266	11,988 Added 50.35%	35,799 $591,000
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $119,010 - $141,617	-9,190 Reduced 27.85%	23,811 $330,000
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $475,874 - $705,891	33,001 New	33,001 $482,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.